⌘K

Login Start Free

Home/Filings/4/0001127602-22-012860

4//SEC Filing

LANGER ROBERT 4

Accession 0001127602-22-012860

CIK 0001682852other

View on SEC.gov Company Profile

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:45 PM ET

Size

11.1 KB

Accession

0001127602-22-012860

Insider Transaction Report

Form 4

Period: 2022-04-28

Moderna, Inc.MRNA

Director

Transactions

Award
Stock Option (Right to Buy)
2022-04-28+5,415→ 5,415 total
Exercise: $142.52→ Common Stock (5,415 underlying)
Exercise/Conversion
Common Stock
2022-04-28+703→ 11,467,664 total
Exercise/Conversion
Restricted Stock Units
2022-04-28−703→ 0 total
Exercise: $0.00→ Common Stock (703 underlying)

Holdings

Common Stock
(indirect: By Trust)
14,132
Common Stock
(indirect: By Trust)
14,132
Common Stock
(indirect: By Trust)
14,132

Footnotes (3)

[F1]Restricted stock units convert into common stock on a one-for-one basis.
[F2]The shares subject to this restricted stock unit award vested in full on April 28, 2022.
[F3]This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001239757

Filing Metadata

Form type: 4
Filed: May 1, 8:00 PM ET
Accepted: May 2, 4:45 PM ET
Size: 11.1 KB

View on SEC.gov